Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,770.78 +867.35 (+1.38%) CMC Crypto 200
1,343.88 -52.65 (-3.77%)
Teladoc Health, Inc. (TDOC)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.20B |
| Enterprise value | 2.67B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.82 |
| Price/book (mrq) | 0.95 |
| Enterprise value/revenue | 1.03 |
| Enterprise value/EBITDA | 17.35 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.94 |
| 52-week change 3 | -51.94% |
| S&P500 52-week change 3 | 22.36% |
| 52-week high 3 | 30.41 |
| 52-week low 3 | 12.65 |
| 50-day moving average 3 | 14.98 |
| 200-day moving average 3 | 19.25 |
Share statistics
| Avg vol (3-month) 3 | 5.05M |
| Avg vol (10-day) 3 | 5.55M |
| Shares outstanding 5 | 169.31M |
| Implied shares outstanding 6 | 169.31M |
| Float 8 | 168.08M |
| % held by insiders 1 | 0.77% |
| % held by institutions 1 | 71.34% |
| Shares short (15 Apr 2024) 4 | 26.81M |
| Short ratio (15 Apr 2024) 4 | 6.4 |
| Short % of float (15 Apr 2024) 4 | 20.64% |
| Short % of shares outstanding (15 Apr 2024) 4 | 15.83% |
| Shares short (prior month 15 Mar 2024) 4 | 20.28M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -8.90% |
| Operating margin (ttm) | -11.93% |
Management effectiveness
| Return on assets (ttm) | -3.25% |
| Return on equity (ttm) | -10.18% |
Income statement
| Revenue (ttm) | 2.62B |
| Revenue per share (ttm) | 15.80 |
| Quarterly revenue growth (yoy) | 2.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 46.03M |
| Net income avi to common (ttm) | -233.03M |
| Diluted EPS (ttm) | -1.34 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.1B |
| Total cash per share (mrq) | 6.47 |
| Total debt (mrq) | 1.59B |
| Total debt/equity (mrq) | 69.48% |
| Current ratio (mrq) | 3.82 |
| Book value per share (mrq) | 13.52 |
Cash flow statement
| Operating cash flow (ttm) | 345.78M |
| Levered free cash flow (ttm) | 306.86M |
© 2024 Yahoo. All rights reserved.